TABLE 1:

Clinical characteristics of patients with perineural spread of malignant melanoma

Patient no.Age (years)/SexRisk FactorsOriginal Presenting LesionTime to Develop Clinical NeuropathyPathologyDelay in Diagnosis of Perineural DiseaseCranial NeuropathiesBiopsyYears of Follow-UpOutcome
159/MLentigo malignaMass on lower lip11 yearsMucosal13 monthsV2, V3, VIIMandibular nerve4AWD
229/MNone knownMass on lower lip3 yearsDesmoplastic1 monthV3Inferior alveolar nerve5AWD
378/MLentigo malignaPigmented lesion over left forehead1.5 yearsDesmoplastic10 monthsIII, IV, V1, VI, VIISupraorbital nerve, CT-FNA2DOD
441/FNoneRight nasopharyngeal mass3 yearsMucosalN/AV1, V2, VI, VIIInfraorbital nerve1 monthUnknown
570/FFamily history of melanomaMass over right nose2.5 yearsDesmoplastic6 monthsIII, IV, V, VI, VII, VIII, IX, X, XI, XIIInfraorbital nerve, CT-FNA5DOD
649/FNoneMass on upper lip3 yearsDesmoplastic1 monthV2Infraorbital nerve1AWD
770/FLentigo malignaLeft supraorbital skin mass12 yearsSpindle-cell11 monthsIII, V1, VISupraorbital nerve2DOD
864/MNoneLeft infraorbital skin mass3 yearsDesmoplastic8 monthsV1, V2Infraorbital nerve2DOD
  • Note.—AWD, alive with disease; DOD, dead of disease; N/A, not applicable.